Analysis of Lipid Biomarkers of Exposure and Host Response

Summary

The purpose of this prospective, open-label, clinical trial is to establish the feasibility and validity of exhaled breath condensate (EBC) biomarkers for use in studies designed to evaluate harm reduction strategies of smoking. This will be accomplished by measuring selected markers in EBC believed related to the pathogenesis of lung disease before and after a smoking cessation intervention.

Timeline

Start

2005-08-23

Primary completion

2007-09-09

Completion

2007-09-09

Drugs

Indications

No indication recorded.